-
Product Insights
Alpine Start Dev – Range West Apartment Community – Texas
The Alpine Start Dev – Range West Apartment Community – Texas project involves the construction of a residential community with 261 units on 4.45ha of land in Saginaw, Texas, the US. Equip yourself with the essential tools needed to make informed and profitable decisions with our Alpine Start Dev – Range West Apartment Community – Texas report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tazemetostat Hydrobromide in Transitional Cell Carcinoma (Urothelial Cell Carcinoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tazemetostat Hydrobromide in Transitional Cell Carcinoma (Urothelial Cell Carcinoma) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tazemetostat Hydrobromide in Transitional Cell Carcinoma (Urothelial...
-
Product Insights
Net Present Value Model: Alpine Immune Sciences Inc’s Povetacicept
Empower your strategies with our Net Present Value Model: Alpine Immune Sciences Inc's Povetacicept report and make more profitable business decisions.Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Company Insights
Innovation and Patenting activity of Alps Alpine Co Ltd Q1 2024
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Alps Alpine Co Ltd Q1 2024". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Thematic Analysis
Quantum Computing – Thematic Intelligence
Quantum Computing Theme Analysis Report Overview Quantum computers use the properties of quantum physics to store data and perform computations. There are many technologies with the potential to build their foundational quantum bits (qubits). However, it may well be over a decade before companies can deliver the enmeshed systems of high-fidelity qubits needed to usher in the quantum era. The fiendishly difficult engineering problems, excess hype, and pre-revenue phase for many quantum companies mean a protracted quantum winter is in...
-
Product Insights
NewMembranous Glomerulonephritis – Drugs In Development, 2024
Empower your strategies with our Membranous Glomerulonephritis – Drugs In Development, 2024 report and make more profitable business decisions. Membranous Glomerulonephritis or membranous nephropathy is an autoimmune glomerular disease that affects the functioning of kidneys. Idiopathic and commonly seen in adults. It leads to nephrotic syndrome characterized by edema, proteinuria, frothy urine. Secondary causes of glomerulonephritis is NSAIDs induced, HBV, SLE, cancer and other infectious diseases. Edema, weight gain, fatigue, proteinuria are the symptoms and is diagnosed by analyzing protein levels...
-
Product Insights
NewSicca Syndrome (Sjogren) – Drugs In Development, 2024
Empower your strategies with our Sicca Syndrome (Sjogren) – Drugs In Development, 2024 report and make more profitable business decisions. Sjogren's syndrome is an autoimmune disease. It involves the inflammation of glands and other tissues of the body. Symptoms include skin rashes or dry skin, vaginal dryness, persistent dry cough, prolonged fatigue, dry eye, dry mouth, joint pain, swelling, and stiffness. Predisposing factors include age, sex, and rheumatic disease. The Sicca Syndrome (Sjogren) drugs in development market research report provide comprehensive...
-
Product Insights
NewLupus Nephritis – Drugs In Development, 2024
Empower your strategies with our Lupus Nephritis – Drugs In Development, 2024 report and make more profitable business decisions. Lupus nephritis is a severe complication of systemic lupus erythematosus (SLE), an autoimmune disease that affects various organs, tissues, and systems within the body. Lupus nephritis specifically involves inflammation of the kidneys, leading to kidney damage and impaired kidney function. In systSLE, the body's immune system mistakenly attacks its own tissues and organs, including the kidneys, causing inflammation. Not all individuals with...
-
Product Insights
NewMyasthenia Gravis – Drugs In Development, 2024
Empower your strategies with our Myasthenia Gravis – Drugs In Development, 2024 report and make more profitable business decisions. Myasthenia gravis is an autoimmune neuromuscular disease characterized by weakness and rapid fatigue of any of the muscles under voluntary control. Symptoms include drooping of one or both eyelids, diplopia, and difficulty swallowing, chewing, and speaking. Treatment includes immunosuppressants, corticosteroids, and surgery. The Myasthenia Gravis drugs in development market research report provide comprehensive information on the therapeutics under development for Myasthenia Gravis,...
-
Product Insights
NewIgA Nephropathy (Berger’s Disease) – Drugs In Development, 2024
Empower your strategies with our IgA Nephropathy (Berger's Disease) – Drugs In Development, 2024 report and make more profitable business decisions. IgA nephropathy, also known as Berger's disease, is a kidney disorder characterized by the buildup of the antibody immunoglobulin A (IgA) in the small blood vessels (glomeruli) within the kidneys. This condition can lead to inflammation, damage, and scarring of the kidneys, affecting their ability to filter waste and excess fluids from the blood. The exact cause of IgA nephropathy...